60,000 doses of Merck’s anti-COVID pill arrive in Israel

This undated image provided by Merck & Co. shows its new antiviral medication (Merck & Co. via AP)
This undated image provided by Merck & Co. shows its new antiviral medication (Merck & Co. via AP)

A shipment of approximately 60,000 doses of Merck’s anti-COVID pill lands at Ben Gurion International Airport, according to Hebrew media reports.

The Health Ministry granted approval to the pill, known as molnupiravir and sold under the name Lagevrio, earlier this month.

The pill has been reported to cut the hospitalization rate in half among patients with early signs of COVID-19. Britain, the European Union and the US authorized its use in recent months.

Israel’s first shipment of Paxlovid, Pfizer’s COVID-fighting pill, arrived in Israel a month ago.

AP contributed to this report.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.